News &amp; Updates

Nicorette® QuickMist Launch Symposium

During the launch of Nicorette^® QuickMist at the Kuala Lumpur Nicotine Addiction International Conference (KLNAC) 2023, a panel of distinguished experts led the discussion on the role of Nicotine Replacement Therapy (NRT) on smoking cessation management. The panel comprised of notable experts, including Professor Chris Bullen (New Zealand), Associate Professor Dr Amer Siddiq bin Amer Nordin (Malaysia), Dr Philip Tønnesen (Denmark) and Professor Philip Eng (Singapore).

Nicorette® QuickMist Launch Symposium

Linaclotide works well for functional constipation in children

The guanylate cyclase C agonist linaclotide helps increase the frequency of bowel movements in children with functional constipation, according to data from a phase III trial.

Linaclotide works well for functional constipation in children

Mirtazapine ups calorie consumption in NSCLC patients with anorexia

In advanced nonsmall cell lung cancer (NSCLC) patients with anorexia, treatment with mirtazapine leads to a substantial increase in energy intake despite having no effect on appetite, as shown in a study.

Mirtazapine ups calorie consumption in NSCLC patients with anorexia

Diagonal earlobe crease tied to higher cardiovascular risk

A diagonal earlobe crease, especially when it is complete, bilateral, deep, and has accessory creases, appears to independently predict an increased cardiovascular risk, reveals a study.

Diagonal earlobe crease tied to higher cardiovascular risk

18 Jan 2024

Unhealthy lifestyles raise risk of cardiac events in low-risk AF patients

Having an unhealthy lifestyle, such as smoking, drinking, and being sedentary, can increase the risk of clinical events in patients with atrial fibrillation (AF) who are at low risk of stroke, reports a study.

Unhealthy lifestyles raise risk of cardiac events in low-risk AF patients

18 Jan 2024

HFNT provides relief for patients with dyspnoea

High-flow nasal cannula therapy (HFNT) is effective in reducing the intensity of the sensory and affective components of dyspnoea, independent of oxygen addition, suggests a study.

HFNT provides relief for patients with dyspnoea

Oesophageal cancer survivors more prone to late-onset pneumonia

Oesophageal cancer survivors are more likely to develop late-onset pneumonia during their clinical course, a study suggests.

Oesophageal cancer survivors more prone to late-onset pneumonia

Original New Drug Application Approvals by US FDA (01-15 January 2024)

New drug applications approved by US FDA as of 01-15 January 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 January 2024)

Sarawak General Hospital's Clinical Research Centre is the first site in the Asia-Pacific region for first-in-human clinical trial on new SLE drug